Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9
about
Potential role of herbal remedies in stem cell therapy: proliferation and differentiation of human mesenchymal stromal cellsRegenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem CellsStromal cell-based immunotherapy in transplantationDifferentiation of mesenchymal stem cells into gonad and adrenal steroidogenic cellsHuman mesenchymal stromal cell-mediated immunoregulation: mechanisms of action and clinical applicationsMesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal modelsMesenchymal stem cells as a gene delivery vehicle for successful islet transplantation.Bioengineering a highly vascularized matrix for the ectopic transplantation of isletsRecipient Glycemic Micro-environments Govern Therapeutic Effects of Mesenchymal Stem Cell Infusion on OsteopeniaMMP9 integrates multiple immunoregulatory pathways that discriminate high suppressive activity of human mesenchymal stem cells.Prolonged Survival of Subcutaneous Allogeneic Islet Graft by Donor Chimerism without Immunosuppressive Treatment.Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantationThe influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction.Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines.Mesenchymal stem cells as feeder cells for pancreatic islet transplantsUmbilical cord-derived mesenchymal stem cells retain immunomodulatory and anti-oxidative activities after neural induction.Mesenchymal stem cells for inducing tolerance in organ transplantationStem cell-based strategies for the treatment of type 1 diabetes mellitusMaintenance of islet morphology is beneficial for transplantation outcome in diabetic mice.Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunctionCooperation by fibroblasts and bone marrow-mesenchymal stem cells to improve pancreatic rat-to-mouse islet xenotransplantationMesenchymal stem cells facilitate mixed hematopoietic chimerism induction and prevent onset of diabetes in nonobese diabetic miceAdipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome.The use of biomaterials in islet transplantationInducible VEGF expression by human embryonic stem cell-derived mesenchymal stromal cells reduces the minimal islet mass required to reverse diabetes.Genetically modified mesenchymal stem cells for improved islet transplantationComparison of therapeutic characteristics of islet cell transplantation simultaneous with pancreatic mesenchymal stem cell transplantation in rats with Type 1 diabetes mellitus.HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice.Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates.Effects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery.iPSC-MSCs Combined with Low-Dose Rapamycin Induced Islet Allograft Tolerance Through Suppressing Th1 and Enhancing Regulatory T-Cell Differentiation.Mesenchymal stem cells for the treatment of diabetesClinical operational tolerance after renal transplantation: current status and future challenges.Tolerance-inducing strategies in islet transplantationMesenchymal stromal cells in renal ischemia/reperfusion injury.Controlled release strategies for modulating immune responses to promote tissue regenerationA preclinical evaluation of alternative site for islet allotransplantation.Comparisons of phenotype and immunomodulatory capacity among rhesus bone-marrow-derived mesenchymal stem/stromal cells, multipotent adult progenitor cells, and dermal fibroblasts.Preculturing Islets With Adipose-Derived Mesenchymal Stromal Cells Is an Effective Strategy for Improving Transplantation Efficiency at the Clinically Preferred Intraportal Site.Mesenchymal stem cell-based therapy.
P2860
Q26741837-9F1CB4BD-C7D3-4F8E-B748-C0B8D24FD3ADQ26752205-9ECE2A81-9E72-40A2-B684-A8066A426C90Q26851908-45843812-BBAD-47AE-B919-3542D384988DQ27003727-D2BF6A7D-0027-439E-AA7F-5453AC854875Q27004008-2F436715-76EA-4513-91FC-66BFE3372A4CQ28085080-0A532BC1-5022-4486-8A4F-7366141209DDQ31006569-E3ADC3BC-83BE-4A32-83E9-F6AF3AEA86D9Q33568319-43904116-3684-4507-B2F6-5C8F95C77F3BQ33588206-049CE824-19A6-451E-AB05-2D486B9F2541Q33678477-61A2D5A0-2CB1-4F78-BFB6-30663751F5A0Q33872942-FF121954-6D8F-41AA-B11A-3CED70B1E235Q34097940-4F3E2F3A-D070-44F6-AD8C-926224EE640EQ34257083-4809C22C-FFB4-4D8A-A322-16D7C69A342BQ34292905-0B92AAD9-C0A2-4704-87A4-E4EFEECE6CC1Q34340690-D25EB3F3-B988-40F5-95E1-3F58992C149CQ34358275-10971308-A576-4BE5-8350-1E3197F02518Q34391029-9D775A53-33E0-4E45-BE3D-BC8E0C373849Q34417324-4A32F0F0-0254-41D6-836C-D7DFE8ED63AFQ34603880-27403AC7-7A5D-4493-A263-AD4CDB3BC3D5Q34873308-8558AE78-3172-469F-B303-3DB895A155E0Q34979813-6BFA8081-4C2B-4C4E-B03B-A26159EC3C94Q35112634-79A1CD2B-74F0-43CB-980C-8949F8F046E1Q35137384-AFB10064-39D1-45D7-BF39-4F26D618B142Q35196565-DA398F03-C2EB-4C69-B1B5-31BC1C93521BQ35227182-69D44096-4122-4248-9746-C27E6661E486Q35256103-7D6C0607-C557-427D-A0D2-AC569B201315Q35313985-18129C07-CD5D-4E32-B949-DF07D8FCE9D8Q35660316-66287CE1-478E-467F-B675-039CA87D5979Q35757109-0BF32CB9-1BE4-4975-89CF-FBC1681F1187Q35861206-70CACFDC-49AF-4110-B01A-4FAF02B8F38BQ35866047-8762C4C3-94F4-49A8-944E-5BD988EC4385Q35976665-3B24C7F0-3613-4CEA-977E-4B4A0B3E8BBEQ35991484-8076DE85-8D67-4604-922A-F38E7F7E9C8CQ36004707-566AA78C-14EE-4344-B28C-16D36C1DB4D6Q36070565-2014D2F0-8C40-4BF4-AA95-7151031B1DBDQ36307642-A3F1530D-05E7-421E-9AC8-990C558A602CQ36328275-F280490F-FBF2-4E5D-A270-3C27856F1602Q36424556-C1D4F29C-148A-46D3-BBC0-7EB437114CBDQ36523515-500E521E-13A7-4909-8051-FFBE2D101D47Q36546424-3E61AE25-17B6-4615-B4B7-238FEE4A97AE
P2860
Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Mesenchymal stem cells prevent ...... rix metalloproteinase-2 and -9
@en
Mesenchymal stem cells prevent ...... rix metalloproteinase-2 and -9
@nl
type
label
Mesenchymal stem cells prevent ...... rix metalloproteinase-2 and -9
@en
Mesenchymal stem cells prevent ...... rix metalloproteinase-2 and -9
@nl
prefLabel
Mesenchymal stem cells prevent ...... rix metalloproteinase-2 and -9
@en
Mesenchymal stem cells prevent ...... rix metalloproteinase-2 and -9
@nl
P2093
P2860
P356
P1433
P1476
Mesenchymal stem cells prevent ...... rix metalloproteinase-2 and -9
@en
P2093
Andrew Bushell
Kathryn J Wood
Ruth J Muschel
Yunchuan Ding
P2860
P304
P356
10.2337/DB09-0317
P407
P577
2009-06-09T00:00:00Z